446 related articles for article (PubMed ID: 9669506)
1. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
2. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
[TBL] [Abstract][Full Text] [Related]
3. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Béïque JC; de Montigny C; Blier P; Debonnel G
Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.
Hébert C; Habimana A; Elie R; Reader TA
Neurochem Int; 2001 Jan; 38(1):63-74. PubMed ID: 10913689
[TBL] [Abstract][Full Text] [Related]
6. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
8. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 3 beta-aryl-8-azabicyclo[3.2.1]octanes with high binding affinities and selectivities for the serotonin transporter site.
Davies HM; Kuhn LA; Thornley C; Matasi JJ; Sexton T; Childers SR
J Med Chem; 1996 Jun; 39(13):2554-8. PubMed ID: 8691453
[TBL] [Abstract][Full Text] [Related]
11. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
[TBL] [Abstract][Full Text] [Related]
12. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs.
Blough BE; Abraham P; Lewin AH; Kuhar MJ; Boja JW; Carroll FI
J Med Chem; 1996 Sep; 39(20):4027-35. PubMed ID: 8831768
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter.
Emond P; Garreau L; Chalon S; Boazi M; Caillet M; Bricard J; Frangin Y; Mauclaire L; Besnard JC; Guilloteau D
J Med Chem; 1997 Apr; 40(9):1366-72. PubMed ID: 9135033
[TBL] [Abstract][Full Text] [Related]
15. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Bel N; Artigas F
J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
[TBL] [Abstract][Full Text] [Related]
18. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
Gurevich EV; Joyce JN
Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
[TBL] [Abstract][Full Text] [Related]
19. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Rueter LE; Kasamo K; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
